Connection

BRENDAN LEE to Osteoblasts

This is a "connection" page, showing publications BRENDAN LEE has written about Osteoblasts.
Connection Strength

2.431
  1. The IFITM5 mutation in osteogenesis imperfecta type V is associated with an ERK/SOX9-dependent osteoprogenitor differentiation defect. J Clin Invest. 2024 Jun 17; 134(15).
    View in: PubMed
    Score: 0.815
  2. Fkbp10 Deletion in Osteoblasts Leads to Qualitative Defects in Bone. J Bone Miner Res. 2017 Jun; 32(6):1354-1367.
    View in: PubMed
    Score: 0.493
  3. The swaying mouse as a model of osteogenesis imperfecta caused by WNT1 mutations. Hum Mol Genet. 2014 Aug 01; 23(15):4035-42.
    View in: PubMed
    Score: 0.400
  4. miRNA-34c regulates Notch signaling during bone development. Hum Mol Genet. 2012 Jul 01; 21(13):2991-3000.
    View in: PubMed
    Score: 0.350
  5. Boosting glycolysis to combat fragile bone in type 1 diabetes. Cell Chem Biol. 2023 09 21; 30(9):1002-1003.
    View in: PubMed
    Score: 0.194
  6. Notch activation as a driver of osteogenic sarcoma. Cancer Cell. 2014 Sep 08; 26(3):390-401.
    View in: PubMed
    Score: 0.103
  7. 4-PBA Treatment Improves Bone Phenotypes in the Aga2 Mouse Model of Osteogenesis Imperfecta. J Bone Miner Res. 2022 04; 37(4):675-686.
    View in: PubMed
    Score: 0.043
  8. Therapeutic Antibody Targeting Tumor- and Osteoblastic Niche-Derived Jagged1 Sensitizes Bone Metastasis to Chemotherapy. Cancer Cell. 2017 Dec 11; 32(6):731-747.e6.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.